Chemoradiotherapy Following Immunotherapy Plus Chemotherapy for Locally-advanced Esophageal Squamous Cell Cancer (RICE)

Clinical trial NCT05621707 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05621707
Sponsor: Shanghai Chest Hospital
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Esophageal Squamous Cell Carcinomas Concurrent Chemoradiotherapy Immunotherapy Chemotherapy

Start date: 2022-11-02
Primary completion: 2026-10-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.